PRISM BioLab None
PRISM BioLab is a biotechnology company that develops therapeutic agents to treat non-oncology indications, including pulmonary fibrosis and incurable diseases. The company's mission is to use its proprietary PepMetics® Technology to transform "undruggable" diseases into "druggable" ones and find cures for incurable diseases. The technology is a drug discovery platform that uses PepMetics Molecules designed to imitate α-helix or β-turn peptides.
Connections
Headquarters:
Fujisawa, Kanagawa, Japan
Estimated Revenue:
53.2